New research, supported by our BRC Molecular Targets’ Theme Co-Leads Professors Paul Harrison and Rachel Upthegrove and BRC Dementia Theme Co-Lead Professor Masud Husain, has found that patients who were hospitalised with COVID-19 showed higher levels of cognitive impairment.
The article, “Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction”, was published recently in Nature Medicine.
The national study compared over 350 patients one year after hospitalisation for COVID-19 to over 2,900 people in a control group.
The findings provide more evidence, that people, one year after COVID are at greater risk of cognitive deficits, and show smaller size of part of the brain, and have elevated blood markers of brain injury.
